ICON plc
ICON plc is one of the world’s largest full-service CROs, with major capabilities across clinical trial management, site and patient services, data management, biostatistics, pharmacovigilance, regulatory affairs, decentralized trial support, and real-world evidence. Its acquisition of PRA Health Sciences significantly expanded its global scale and therapeutic coverage.
- Highest 2026 tier: Tier I
- Contract Research Organizations
- 1 ranking category
Overview
ICON plc is one of the world’s largest full-service CROs, with major capabilities across clinical trial management, site and patient services, data management, biostatistics, pharmacovigilance, regulatory affairs, decentralized trial support, and real-world evidence. Its acquisition of PRA Health Sciences significantly expanded its global scale and therapeutic coverage.
ICON’s strength lies in its ability to support large multinational clinical trials for pharmaceutical, biotechnology, and medical device sponsors. The company has deep experience across therapeutic areas including oncology, cardiovascular disease, infectious disease, neuroscience, rare disease, and vaccines.
ICON plc is included in 1 2026 ranking category. Its highest classification is Tier I. Ranking recognition is category-specific editorial evidence rather than a substitute for independent diligence.
Firm facts
| Public identity | ICON plc |
| Founded | 1990 |
| Institution type | Contract Research Organizations institution |
| Headquarters | Dublin, Ireland |
| Primary focus | Contract Research Organizations |
| Highest 2026 ranking tier | Tier I |
Principal activities
ICON’s strength lies in its ability to support large multinational clinical trials for pharmaceutical, biotechnology, and medical device sponsors. The company has deep experience across therapeutic areas including oncology, cardiovascular disease, infectious disease, neuroscience, rare disease, and vaccines.
Core capability
Contract Research Organizations
Client relevance
Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.
Execution and verification
Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.
Sector and mandate coverage
Primary category
Contract Research Organizations
Institutional context
Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.
Market position
ICON’s global clinical operations, large sponsor base, trial execution infrastructure, and therapeutic breadth support its Tier I position, while governance and reporting issues should remain a point of monitoring.
ICON plc is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier I.
Competitive context
The relevant peer set varies by category, geography, client segment and mandate. ICON plc should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.
Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.
Leadership and governance
Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.
Corporate and public information
The public-facing organization is identified here as ICON plc. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.
Corporate and disclosure information
| Organization | ICON plc |
| Headquarters | Dublin, Ireland |
| Verification note | Confirm legal entity, licenses, offices and engagement terms directly before appointment or use. |
Rankings and recognition
Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.
Related Economy analysis
Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:
- Healthcare Rankings and the New Economics of Expertise
- Healthcare Market Structure Is Opening a New Lane for Specialist Providers
- Healthcare Rankings and the New Geography of Distributed Care
Related institutions and subjects
Sources and data transparency
Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.
- Healthcare Ranking — Top 30 Contract Research Organizations 2026 — 2026 inclusion and tier classification.
- The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
- The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
- The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.
